PHAR (Pharming Group N.V.) Short-Term Debt to Capital
Pharming Group N.V. (PHAR) generates revenue through the sale of patented biologics for the treatment of hereditary angioedema via insurance reimbursements. This price action chart on GURU.Markets shows that the indicator is 0.07. Price stability is underpinned by a staff of leading Western scientists, which eliminates any talent shortage. In the long term, growth is supported by a strategic focus on protein bioengineering and the therapy of orphan diseases.
Analytical breakdowns for Pharming Group N.V.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Fundamental valuation:Pharming
Pharming Group N.V. maintains a monopoly position in the orphan drug segment, where its unique biotechnologies generate a steady cash flow that minimizes reliance on external borrowing. By analyzing the short-term debt to equity ratio, investors assess the relationship between short-term liabilities and equity, allowing them to identify liquidity risks or excessive resource management conservatism through the extremes on the chart.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio NKTR|Short-Term Debt to Capital Upstream Pharma|Short-Term Debt to Equity Zenas Biopharma Inc (ZBIO)|immunome.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Current Liabilities to Capital|SEPN - Short-Term Debt to Equity|Current Liabilities to Equity PVLA|SVRA: Short-Term Debt to Capital|rigel.com - Ratio of Short-Term Indebtedness to Capital|ANAB (AnaptysBio) - Short-Term Debt to Capital|Short-Term Debt to Capital Astria Therapeutics Inc|Short-Term Debt to Equity enGene Bio (ENGN)|RAPT (rapt.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Aerovate Therapeutics JBIO|ACRS - Short-Term Debt to Equity Ratio|Kyverna Therapeutics, Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Tiziana Life Sciences Ltd. TLSA|Cabaletta Bio, Inc (CABA) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio VTYX|THTX (Theratechnologies Inc.) - Short-Term Debt to Capital|AVTX - Short-Term Indebtedness to Equity|Short-Term Debt to Equity Ratio ELDN (Eledon Pharmaceuticals, Inc.)|AGEN (Agenus, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital CLYM (Climb Bio, Inc.)|Short-Term Indebtedness to Equity zurabio.com|ATYR - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital ADAG (Adagene)|ikenaoncology.com (IMA) - Short-Term Debt to Equity|Current Liabilities to Capital Shattuck Labs (STTK)|Short-Term Debt to Equity Ratio EQ|Short-Term Debt to Capital Connect Pharma|Short-Term Debt to Equity Immunic, Inc. (IMUX)|ATRA: Current Liabilities to Equity|InflaRx - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital XFOR|ACET - Short-Term Debt to Equity|CELU (Celularity Inc.) - Short-Term Debt to Capital Ratio|INMB (INmune Bio, Inc.) - Short-Term Debt to Equity Ratio|BRNS - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio KZR|Short-Term Debt to Equity SABS|Short-Term Debt to Equity Ratio AKTX (Akari Therapeutics plc)|Short-Term Debt to Capital Coefficient enlivex.com|Short-Term Debt to Equity Q32 Bio QTTB|GOVX (geovax.com) - Current Liabilities to Equity|Edesa Biotech - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital IBIO (iBio Inc)|CARM: Short-Term Debt to Capital|XTL Bio (XTLB) - Short-Term Debt to Capital|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|HCWB: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Aptevo Therapeutics (APVO)|AIM: Current Liabilities to Equity|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|Ratio of Short-Term Indebtedness to Capital GRI|XORTX Therapeutics Inc. - Short-Term Debt to Capital|HIND - Short-Term Debt to Capital|Revelation Biosciences, Inc. (REVB) - Short-Term Debt to Equity|Indaptus Therapeutics Inc - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Scinai|Short-Term Debt to Equity Ratio CalciMedica Corp (CALI)|Short-Term Debt to Capital AFMD|Short-Term Debt to Capital allakos.com (ALLK)|HOOKIPA Pharma - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital IGMS|iTeos - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Ocean Biomedical Corp OCEA|TC Biopharm (TCBP) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio thirdharmonicbio.com